NIO To Rally Around 65%? Here Are 10 Top Analyst Forecasts For Friday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several companies, including NIO, Planet Labs, Methode Electronics, Travere Therapeutics, Samsara, Hubbell, Core & Main, UiPath, Guidewire Software, and Bloom Energy. Notable changes include JP Morgan's upgrade of NIO and Jefferies' downgrade of Bloom Energy.
September 06, 2024 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jefferies downgraded Bloom Energy from Buy to Hold and cut the price target from $15 to $11. Shares fell 1.3% to $11.03.
The downgrade and reduced price target are negative signals, likely leading to further short-term declines in Bloom Energy's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Goldman Sachs cut Core & Main's price target from $57 to $50, maintaining a Neutral rating. Shares fell 3.6% to $38.00.
The reduced price target and share price drop suggest negative sentiment, likely leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Baird reduced Methode Electronics' price target from $15 to $13, maintaining a Neutral rating. Shares gained 2.8% to $10.34.
Despite the lowered price target, the Neutral rating and recent share gain suggest a balanced outlook. The short-term impact is likely neutral.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
BMO Capital raised UiPath's price target from $14 to $15, maintaining a Market Perform rating. Shares rose 0.2% to $12.74.
The slight increase in price target and Market Perform rating suggest a stable outlook, with minimal short-term impact expected.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 80
NEUTRAL IMPACT
Needham cut the price target for Planet Labs from $7 to $5 but maintained a Buy rating. Shares closed at $2.48.
The reduction in price target by Needham suggests a more cautious outlook, but the maintained Buy rating indicates continued long-term potential. The impact on short-term price is neutral.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Oppenheimer increased Guidewire Software's price target from $170 to $185, maintaining an Outperform rating. Shares fell 2.1% to $143.93.
The increased price target and Outperform rating indicate strong long-term potential, which may lead to a positive short-term impact as investors adjust.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Deutsche Bank upgraded Hubbell to Buy and increased the price target from $431 to $441. Shares fell 1.2% to $370.42.
The upgrade to Buy and increased price target are positive indicators, suggesting potential for a rebound despite the recent share price drop.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
B of A Securities raised Samsara's price target from $45 to $47, maintaining a Buy rating. Shares gained 0.2% to $38.75.
The raised price target and Buy rating suggest positive sentiment, likely supporting a slight upward trend in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
JP Morgan upgraded NIO from Neutral to Overweight and increased the price target from $5.3 to $8, leading to a 14.4% gain in NIO shares.
JP Morgan's upgrade and increased price target for NIO is a strong positive signal, likely driving the 14.4% increase in share price. This suggests increased investor confidence and potential for further gains.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
HC Wainwright & Co raised Travere Therapeutics' price target from $20 to $23, maintaining a Buy rating. Shares fell 1.2% to $9.93.
The increased price target and Buy rating indicate positive long-term prospects, despite the recent share price drop. This could lead to a positive short-term impact as investors digest the news.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80